PET-CT for radiotherapy treatment planning and response monitoring in solid tumors

被引:67
作者
Bussink, Johan [1 ]
Kaanders, Johannes H. A. M. [1 ]
van der Graaf, Winette T. A. [2 ]
Oyen, Wim J. G. [3 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands
关键词
POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; F-18 FLUORODEOXYGLUCOSE UPTAKE; NECK-CANCER; RADIATION ONCOLOGY; CONVENTIONAL RADIOTHERAPY; ACCELERATED RADIOTHERAPY; BREAST-CANCER; ESOPHAGOGASTRIC JUNCTION; IMAGING PROLIFERATION;
D O I
10.1038/nrclinonc.2010.218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PET imaging has evolved as an indispensible tool for staging in oncology. Multiple quantitative measurements can be performed, enabling the effects of treatment to be monitored before changes are detectable with the use of conventional imaging modalities. PET tracers are available to visualize and quantify the most important mechanisms of resistance to radiotherapy and chemoradiotherapy. Reproducibility of these tracers depends on the particular tracer and the underlying biology of the process that is being investigated. PET enables clinicians to select patients for intensified treatment on the basis of resistance mechanisms taking place at the molecular level. From translational studies and randomized trials, it has become clear that appropriate patient selection can prevent unnecessary rejection of various treatment options through the observation of individual patients rather than only looking at the results of a large study population.
引用
收藏
页码:233 / 242
页数:10
相关论文
共 101 条
[1]   Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan [J].
Aerts, Hugo J. W. L. ;
van Baardwijk, Angela A. W. ;
Petit, Steven F. ;
Offermann, Claudia ;
van Loon, Judith ;
Houben, Ruud ;
Dingemans, Anne-Marie C. ;
Wanders, Rinus ;
Boersma, Liesbeth ;
Borger, Jacques ;
Bootsma, Gerben ;
Geraedts, Wiel ;
Pitz, Cordula ;
Simons, Jean ;
Wouters, Bradly G. ;
Oellers, Michel ;
Lambin, Philippe ;
Bosmans, Geert ;
Dekker, Andre L. A. J. ;
De Ruysscher, Dirk .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) :386-392
[2]   EVIDENCE THAT HYPOXIA MARKERS DETECT OXYGEN GRADIENTS IN LIVER - PIMONIDAZOLE AND RETROGRADE PERFUSION OF RAT-LIVER [J].
ARTEEL, GE ;
THURMAN, RG ;
YATES, JM ;
RALEIGH, JA .
BRITISH JOURNAL OF CANCER, 1995, 72 (04) :889-895
[3]   Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data [J].
Auperin, A. ;
Le Chevalier, T. ;
Le Pechoux, C. ;
Pignon, J. P. ;
Tribodet, H. ;
Burdett, S. ;
Stewart, L. A. ;
Tierney, J. F. ;
Stephens, R. J. ;
Arriagada, R. ;
Higgins, J. P. ;
Johnson, D. H. ;
van Meerbeeck, J. ;
Parmar, M. K. B. ;
Souhami, R. L. ;
Bergman, B. ;
Dautzenberg, B. ;
Douillard, J. Y. ;
Dunant, A. ;
Endo, C. ;
Girling, D. J. ;
Imaizumi, M. ;
Kato, H. ;
Keller, S. M. ;
Kimura, H. ;
Knuuttila, A. ;
Kodama, K. ;
Komaki, R. ;
Kris, M. G. ;
Lad, T. ;
Mineo, T. ;
Park, J. H. ;
Piantadosi, S. ;
Pyrhonen, S. ;
Rosell, R. ;
Scagliotti, G. V. ;
Seymour, L. W. ;
Shepherd, F. A. ;
Spiro, S. G. ;
Strauss, G. M. ;
Sylvester, R. ;
Tada, H. ;
Tanaka, F. ;
Torri, V. ;
Wada, H. ;
Waller, D. ;
Xu, G. C. .
LANCET, 2010, 375 (9722) :1267-1277
[4]   Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer [J].
Auperin, Anne ;
Le Pechoux, Cecile ;
Rolland, Estelle ;
Curran, Walter J. ;
Furuse, Kiyoyuki ;
Fournel, Pierre ;
Belderbos, Jose ;
Clamon, Gerald ;
Ulutin, Hakki Cuneyt ;
Paulus, Rebecca ;
Yamanaka, Takeharu ;
Bozonnat, Marie-Cecile ;
Uitterhoeve, Apollonia ;
Wang, Xiaofei ;
Stewart, Lesley ;
Arriagada, Rodrigo ;
Burdett, Sarah ;
Pignon, Jean-Pierre .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2181-2190
[5]   The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis [J].
Begg, AC ;
Haustermans, K ;
Hart, AAM ;
Dische, S ;
Saunders, M ;
Zackrisson, B ;
Gustaffson, H ;
Coucke, P ;
Paschoud, N ;
Hoyer, M ;
Overgaard, J ;
Antognoni, P ;
Richetti, A ;
Bourhis, J ;
Bartelink, H ;
Horiot, JC ;
Corvo, R ;
Giaretti, W ;
Awwad, H ;
Shouman, T ;
Jouffroy, T ;
Maciorowski, Z ;
Dobrowsky, W ;
Struikmans, H ;
Rutgers, D ;
Wilson, GD .
RADIOTHERAPY AND ONCOLOGY, 1999, 50 (01) :13-23
[6]   Theragnostic imaging for radiation oncology: dose-painting by numbers [J].
Bentzen, SM .
LANCET ONCOLOGY, 2005, 6 (02) :112-117
[7]   FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas [J].
Benz, Matthias R. ;
Czernin, Johannes ;
Allen-Auerbach, Martin S. ;
Tap, William D. ;
Dry, Sarah M. ;
Elashoff, David ;
Chow, Kira ;
Evilevitch, Vladimir ;
Eckardt, Jeff J. ;
Phelps, Michael E. ;
Weber, Wolfgang A. ;
Eilber, Fritz C. .
CLINICAL CANCER RESEARCH, 2009, 15 (08) :2856-2863
[8]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[9]   Hyperfractionated or accelerated radiotherapy in head and neck cancer:: a meta-analysis [J].
Bourhis, Jean ;
Overgaard, Jens ;
Audry, Helene ;
Ang, Kian K. ;
Saunders, Michele ;
Bernier, Jacques ;
Horiot, Jean-Claude ;
Le Maitre, Aurlie ;
Pajak, Thomas F. ;
Paulsen, Michael G. ;
O'Sullivan, Brian ;
Dobrowsky, Werner ;
Hliniak, Andrzej ;
Skladowski, Krzysztof ;
Hay, John H. ;
Pinto, Luiz H. J. ;
Fallai, Carlo ;
Fu, Karen K. ;
Sylvester, Richard ;
Pignon, Jean-Pierre .
LANCET, 2006, 368 (9538) :843-854
[10]   Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood [J].
Bremnes, RM ;
Camps, C ;
Sirera, R .
LUNG CANCER, 2006, 51 (02) :143-158